BIOCRYST PHARMACEUTICALS, INC. (BCRX) Revenue 2016–2025
BIOCRYST PHARMACEUTICALS, INC. (BCRX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$874.8MFY2025 · since FY2016: $26.4M → $874.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $874.8M | +94.1% |
| FY2024 | $450.7M | +36.0% |
| FY2023 | $331.4M | +22.4% |
| FY2022 | $270.8M | +72.3% |
| FY2021 | $157.2M | +782.4% |
| FY2020 | $17.8M | -63.5% |
| FY2019 | $48.8M | +136.5% |
| FY2018 | $20.7M | -18.0% |
| FY2017 | $25.2M | -4.4% |
| FY2016 | $26.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice